首页> 外文会议>SPIE Conference on Frontiers in Pathogen Detection >Energy Transfer-Based Biosensing of Protease Activity Measured Using an Electroluminescent Platform
【24h】

Energy Transfer-Based Biosensing of Protease Activity Measured Using an Electroluminescent Platform

机译:使用电致发光平台测量的蛋白酶活性的能量转移基础溶解

获取原文

摘要

We present a biosensing platform that uses spatial electroluminescent (EL) illumination combined with charge-coupled device (CCD)-based detection for fluorescence measurements. The resulting EL-CCD detector platform was used to monitor different protease activities with substrates labeled for fluorescence resonance energy transfer (FRET)-based assays. The first uses a commercial FITC/DABCYL-SNAP-25 peptide substrate to monitor the activity of the light chain derivative (LcA) of botulinum neurotoxin A, achieving a limit of detection (LOD) of 1.25 nM (62 ng/ml). The second protease activity assay measured trypsin proteolysis using peptide substrates immobilized onto semiconductor quantum dot (QD) nanoparticles with a LOD of 6.2 nM trypsin (140 ng/ml). The specific ovomucoid inhibition of trypsin activity was also monitored. The highlighted studies clearly demonstrate the utility of the EL-CCD detector platform for monitoring fluorescent-based protease activity assays with potential healthcare applications, including pointof- care diagnostics.
机译:我们介绍了一种生物传感平台,使用空间电致发光(EL)照明与电荷耦合器件(CCD)的基于检测进行荧光测量。所得到的EL-CCD检测器平台用于监测与标记的荧光共振能量转移(荧光)的底物的不同蛋白酶活性。基础的测定。首先使用商业FITC / dabcyl-SNAP-25肽基底来监测肉毒杆菌神经毒素A的轻链衍生物(LCA)的活性,从而实现1.25nm(62ng / ml)的检测限。第二种蛋白酶活性测定使用固定在半导体量子点(QD)纳米颗粒上的肽基材的胰蛋白酶蛋白分解,其具有6.2nm胰蛋白酶(140ng / ml)。还监测了胰蛋白酶活性的特异性卵形抑制。突出的研究清楚地证明了EL-CCD检测器平台用于监测基于荧光的蛋白酶活性测定的效用,包括潜在的医疗保健应用,包括尖端的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号